Evidence mapPaperPMID 41909793Full record

ArticleRSC advances2026

Replicating the post-chemotherapy tumor microenvironment

Zhe Fan, Huiying Zhang, Lulu Wang, Jinxiang Tian, Huaiqing Jiang, Yazhou Chen, Biao Guo, Haiyang Yu

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhe FanDepartment of Orthopedics, Affiliated Fuyang People's Hospital of Anhui Medical University, National Key Clinical Specialty, Clinical Research Center for Spinal Deformity of Anhui Province Fuyang Anhui Province 236000 China fy.yhy@163.com.ORCID https://orcid.org/0009-0006-7760-4189
Huiying ZhangHenan Provincial Chest Hospital, The Chest Hospital of Zhengzhou University Zhengzhou 450006 China.
Lulu WangDepartment of Plastic Surgery, The Third People's Hospital of Henan Province Zhengzhou 450007 Henan China luna0323@163.com.
Jinxiang TianDepartment of Orthopedics, Affiliated Fuyang People's Hospital of Anhui Medical University, National Key Clinical Specialty, Clinical Research Center for Spinal Deformity of Anhui Province Fuyang Anhui Province 236000 China fy.yhy@163.com.
Huaiqing JiangHenan Institute of Advanced Technology, Zhengzhou University Zhengzhou 450003 PR China yzchenbio@zzu.edu.cn.
Yazhou ChenHenan Institute of Advanced Technology, Zhengzhou University Zhengzhou 450003 PR China yzchenbio@zzu.edu.cn.ORCID https://orcid.org/0000-0002-3744-4807
Biao GuoDepartment of Orthopedics, Affiliated Fuyang People's Hospital of Anhui Medical University, National Key Clinical Specialty, Clinical Research Center for Spinal Deformity of Anhui Province Fuyang Anhui Province 236000 China fy.yhy@163.com.
Haiyang YuDepartment of Orthopedics, Affiliated Fuyang People's Hospital of Anhui Medical University, National Key Clinical Specialty, Clinical Research Center for Spinal Deformity of Anhui Province Fuyang Anhui Province 236000 China fy.yhy@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The repair of tumor-induced bone defects requires regenerative materials capable of functioning within the harsh conditions of cancer therapy. Herein, we introduce a biomimetic scaffold designed to simulate the post-chemotherapy tumor microenvironment to investigate its specific effects on tissue regeneration. The scaffold features a PLGA knitted mesh/collagen sponge hybrid loaded with mineralized, DOX-carrying mesoporous silica nanoparticles (DOX-MSNCaP). The sustained release of DOX facilitates potent tumor cell elimination, thereby establishing a residual post-chemotherapy microenvironment. We subsequently explored the biological response of mesenchymal stem cells (MSCs) to this specific biomimetic environment. Our results indicate that the scaffold significantly enhances MSC adhesion and drives osteogenic differentiation through the upregulation of YAP/TAZ signaling. Overall, these findings suggest that following tumor eradication, the scaffold effectively facilitates MSC-mediated osteogenesis, serving as a promising therapeutic strategy for post-tumor bone reconstruction.

Identifiers

PMID41909793
PMCPMC13022758

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.